Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ROCK2 | O75116 | 5/20 | 0.54 |
| ▸ | ROCK1 | Q13464 | 4/20 | 0.54 |
| ▸ | AOC3 | Q16853 | 2/20 | 0.51 |
| ▸ | MTNR1A | P48039 | 3/20 | 0.48 |
| ▸ | MTNR1B | P49286 | 3/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.46 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.46 |
| ▸ | CASR | P41180 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6609429 | 0.87 | AOC3 (0.54) | AOC3MTNR1AMTNR1BL3MBTL1SLC6A2 | |
| SCHEMBL23679234 | 0.82 | GPR139 (0.42) | ROCK2ROCK1SLC6A2 | |
| SCHEMBL17790226 | 0.81 | AOC3 (0.51) | AOC3MTNR1AMTNR1BL3MBTL1SLC6A2 | |
| SCHEMBL9392741 | 0.81 | MTNR1A (0.58) | ROCK2ROCK1AOC3MTNR1AMTNR1B | |
| SCHEMBL8284248 | 0.81 | AOC3 (0.51) | AOC3MTNR1AMTNR1BL3MBTL1SLC6A2 | |
| SCHEMBL21507527 | 0.81 | UTS2R (0.50) | ROCK2ROCK1AOC3SLC6A2SLC6A4 | |
| SCHEMBL11626138 | 0.80 | AOC3 (0.54) | ROCK2ROCK1AOC3MTNR1AMTNR1B | |
| SCHEMBL11174933 | 0.80 | AOC3 (0.50) | ROCK2ROCK1AOC3MTNR1AMTNR1B | |
| SCHEMBL6490320 | 0.80 | AOC3 (0.62) | ROCK2ROCK1AOC3MTNR1AMTNR1B | |
| SCHEMBL24527630 | 0.79 | AOC3 (0.53) | ROCK2ROCK1AOC3MTNR1AMTNR1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3016951-B1 | TRICYCLIC PYRIDO-CARBOXAMIDE DERIVATIVES AS ROCK INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2017-05-31 | — | — | EP | disclosed |